Industries > Pharma > Global Clinical Nutrition Market Forecast 2019-2029

Global Clinical Nutrition Market Forecast 2019-2029

Infant Nutrition, Enteral Nutrition, Parenteral Nutrition

PAGES: 144
PRODUCT CODE: PHA0388

Clear
WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0388 Categories: , Tags: ,

The global clinical nutrition market is estimated at $41bn in 2016 and is expected to grow at a CAGR of 5.3% from 2017-2027. The infant nutrition segment held the largest market share, with $24.1 billion in value in 2016 and is expected to grow at a CAGR of 4.9% for the period 2017-2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 144-page report you will receive 150 charts – all unavailable elsewhere.

The 144-page report provides clear detailed insight into the global clinical nutrition market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Clinical Nutrition Market forecasts from 2019-2029

This report also shows forecast revenue to 2029 for the leading segments and sub segments of the clinical nutrition market:

Infant Nutrition:
– Milk-based
– Soy-based
– Organic
– Probiotic / prebiotic
– Others

Enteral Nutrition
– Standard
– Enteral Nutrition for Chronic Illnesses

Parenteral Nutrition

Our analyses show individual revenue forecasts to 2029 for these regional and national markets:
– North America: the US and Rest of North America
– Europe: Germany, France, the UK and Rest of Europe
– Asia-Pacific: China, Japan, India and Rest of Asia-Pacific
– Rest of the World (RoW): Middle East and Rest of RoW

Global Clinical Nutrition Market Forecast 2017-2027

Each regional market is further segmented into the leading segments and sub segments of the clinical nutrition market. Whereas, each national market is further segmented into the leading segments of the clinical nutrition market.

• This report discusses the leading companies that hold the majority of market shares in the clinical nutrition market:
– Baxter International
– Abbott Laboratories
– B. Braun Melsungen AG
– Nestle S.A.
– Groupe Danone
– Mead Johnson
– Fresenius Kabi
– Hospira
– Perrigo

• This report also discusses Porter’s Five Forces Analysis. These forces analyze the clinical nutrition market from five different perspectives such as competitive rivalry within the industry; threat of new entrants; bargaining power of suppliers; bargaining power of buyers; and threat of substitute products.

Visiongain’s study is intended for anyone requiring commercial analyses for the clinical nutrition market. You find data, trends and predictions.

Buy our report today Global Clinical Nutrition Market Forecast 2019-2029: Infant Nutrition, Enteral Nutrition, Parenteral Nutrition.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Clinical Nutrition Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Clinical Nutrition Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Contract Research Organisations (CROs) Market Report 2022-2032

The global Contract Research Organizations (CROs) market was valued at US$57.1 billion in 2021 and is projected to grow at a CAGR of 9.95% during the forecast period 2022-2032.

12 August 2022

READ

Visiongain Publishes Genome Editing Technologies Market Report 2022-2032

The Global Genome Editing Technologies market is estimated to be valued at US$ 4,225.48 million in 2022. The market is projected to reach a market value of US$ 18,570.41 million by 2032. We predict strong revenue growth through to 2032.

02 August 2022

READ

Visiongain Publishes Synthetic Biology Market Report 2022-2032

The global synthetic biology market was valued at US$13.8 billion in 2021 and is projected to grow at a CAGR of 25.52% during the forecast period 2022-2032.

27 July 2022

READ

Visiongain Publishes Biosimilar Monoclonal Antibodies Market Report 2022-2032

The global biosimilar monoclonal antibodies market was valued at US$4,087 million in 2021 and is projected to grow at a CAGR of 23.5% during the forecast period 2022-2032.

25 July 2022

READ